Is a complete RGNX research report available?

No complete published report is available for REGENXBIO Inc. (RGNX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

REGENXBIO Inc. (RGNX)

NASDAQ: RGNX · USD

$7.28

+0.68 (+10.3%)· Recorded snapshot

Market cap	480.6M
Revenue (ttm)	174.5M
Net income (ttm)	-196.4M
EPS (ttm)	-$3.77
Shares out	66M
Volume	1,760,962
Beta	1.13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 174.5M
Net income (ttm): -196.4M
EPS (ttm): -$3.77
Market cap: 480.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001590877
Company name	REGENXBIO Inc.
Country	United States
Country code	US
CUSIP number	75901B107
Earnings date	2026-11-09
Earnings time	bmo
Employees	371
Employees change	18
Employees growth	5.1%
Enterprise value	$625.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2015-09-17
Is primary listing	Yes
Is SPAC	No
ISIN number	US75901B1070
Last 10-K release date	2026-03-05
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$480.6M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$7.28
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	RGNX
U.S. state	Maryland
Website	https://www.regenxbio.com

Metric

Value

Amount currency

USD

CIK code

0001590877

Company name

REGENXBIO Inc.

Country

United States

Country code

CUSIP number

75901B107

Earnings date

2026-11-09

Earnings time

bmo

Employees

371

Employees change

Employees growth

5.1%

Enterprise value

$625.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2008

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2015-09-17

Is primary listing

Yes

Is SPAC

ISIN number

US75901B1070

Last 10-K release date

2026-03-05

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$480.6M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$7.28

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

RGNX

U.S. state

Maryland

Website

https://www.regenxbio.com

Metric	Value
Earnings yield	-51.72%
EV/Sales	3.41x
FCF / EV yield	-41.95%
FCF yield	-55.46%
Forward EV/Sales	7.19x
Forward P/S	5.44x
P/B ratio	4.98x
P/S ratio	2.58x
Price / tangible book value	6.27x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-51.72%

EV/Sales

3.41x

FCF / EV yield

-41.95%

FCF yield

-55.46%

Forward EV/Sales

7.19x

Forward P/S

5.44x

P/B ratio

4.98x

P/S ratio

2.58x

Price / tangible book value

6.27x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-94.08%
EBITDA margin	-85.27%
Gross margin	-44.95%
Operating margin	-94.08%
Pretax margin	-112.58%
Profit margin	-112.58%
Profit per employee	$-529,466
Profitable quarters	1
Revenue per employee	$470,302
ROA	-21.2%
ROA (5Y)	-15.73%
ROCE	-54%
ROE	-137.63%
ROE (5Y)	-54.31%
ROIC	-97.79%
ROIC (5Y)	-65.82%
SBC / revenue	20.08%

Metric

Value

EBIT margin

-94.08%

EBITDA margin

-85.27%

Gross margin

-44.95%

Operating margin

-94.08%

Pretax margin

-112.58%

Profit margin

-112.58%

Profit per employee

$-529,466

Profitable quarters

Revenue per employee

$470,302

ROA

-21.2%

ROA (5Y)

-15.73%

ROCE

-54%

ROE

-137.63%

ROE (5Y)

-54.31%

ROIC

-97.79%

ROIC (5Y)

-65.82%

SBC / revenue

20.08%

Metric	Value
EPS growth quarters	1
EPS growth years	3
Net income growth quarters	1
Net income growth years	3
Revenue growth	12%
Revenue growth (Q)	405.73%
Revenue growth (QoQ)	1,589.64%
Revenue growth 10Y	35.52%
Revenue growth 3Y	21.63%
Revenue growth 5Y	1.59%
Revenue growth quarters	1
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

12%

Revenue growth (Q)

405.73%

Revenue growth (QoQ)

1,589.64%

Revenue growth 10Y

35.52%

Revenue growth 3Y

21.63%

Revenue growth 5Y

1.59%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-3M
Depreciation and amortization	$15.4M
EBIT	$-164.1M
EBITDA	$-148.8M
EPS	$-3.77
FCF per share	$-3.78
Financing cash flow	$-12.7M
Free cash flow	$-249.7M
Free cash flow minus SBC	$-284.7M
Gross profit	$-78.4M
Investing cash flow	$216.3M
Net cash flow	$-43.1M
Net income	$-196.4M
Operating cash flow minus SBC	$-281.7M
Operating income	$-164.1M
Revenue	$174.5M
Stock-based compensation	$35M

Metric

Value

Capital expenditures

$-3M

Depreciation and amortization

$15.4M

EBIT

$-164.1M

EBITDA

$-148.8M

EPS

$-3.77

FCF per share

$-3.78

Financing cash flow

$-12.7M

Free cash flow

$-249.7M

Free cash flow minus SBC

$-284.7M

Gross profit

$-78.4M

Investing cash flow

$216.3M

Net cash flow

$-43.1M

Net income

$-196.4M

Operating cash flow minus SBC

$-281.7M

Operating income

$-164.1M

Revenue

$174.5M

Stock-based compensation

$35M

Metric	Value
Altman Z-Score	-3.82
Book value per share	$1.32
Debt / equity	3.49
Interest coverage	-3.91
Long-term assets	$150.5M
Long-term liabilities	$232.2M
Net cash (debt)	$-144.9M
Net cash / market cap	-32.19%
Net debt / equity	2.02
Piotroski F-Score	2
Property, plant and equipment	$142.3M
Shareholders' equity	$71.8M
Tangible book value	$71.8M
Tangible book value per share	$1.32
Total assets	$386.6M
Total cash	$105.5M
Total debt	$250.5M
Total liabilities	$314.9M
WACC	11.45%

Metric

Value

Altman Z-Score

-3.82

Book value per share

$1.32

Debt / equity

3.49

Interest coverage

-3.91

Long-term assets

$150.5M

Long-term liabilities

$232.2M

Net cash (debt)

$-144.9M

Net cash / market cap

-32.19%

Net debt / equity

2.02

Piotroski F-Score

Property, plant and equipment

$142.3M

Shareholders' equity

$71.8M

Tangible book value

$71.8M

Tangible book value per share

$1.32

Total assets

$386.6M

Total cash

$105.5M

Total debt

$250.5M

Total liabilities

$314.9M

WACC

11.45%

Metric	Value
Asset turnover	0.36
Current assets	$236.2M
Current liabilities	$82.6M
Current ratio	2.86
Net working capital	$82.1M
Quick ratio	2.7
Working capital	$153.5M
Working capital turnover	0.86

Metric

Value

Asset turnover

0.36

Current assets

$236.2M

Current liabilities

$82.6M

Current ratio

2.86

Net working capital

$82.1M

Quick ratio

2.7

Working capital

$153.5M

Working capital turnover

0.86

Metric	Value
Buyback yield / dilution	-2.03%
Dividend yield	0%
Shareholder yield	-2.03%

Metric

Value

Buyback yield / dilution

-2.03%

Dividend yield

Shareholder yield

-2.03%

Metric	Value
10Y price change	-55.34%
10Y return CAGR	-7.75%
10Y total return	-55.34%
150-day SMA	$8.95
1D price change	10.3%
1M price change	-1.62%
1M total return	-1.62%
1W price change	1.53%
1W total return	1.53%
1Y price change	-46.55%
1Y return CAGR	-46.57%
1Y total return	-46.55%
20-day SMA	$7.29
200-day SMA	$9.25
3M price change	-25.03%
3M total return	-25.03%
3Y price change	-49.37%
3Y return CAGR	-20.3%
3Y total return	-49.37%
50-day SMA	$8.15
50-day SMA vs 200-day SMA	50under200
52-week high	$16.19
52-week high date	2026-01-22
52-week low	$5.46
52-week low date	2026-05-18
5Y price change	-79.33%
5Y return CAGR	-27.05%
5Y total return	-79.33%
6M price change	-15.55%
6M total return	-15.55%
All-time high	$85.10
All-time high date	2018-07-10
All-time low	$5.04
All-time low date	2025-04-09
Average true range (ATR)	$0.49
Average volume	1.4M
Beta (1Y)	3.03
Beta (2Y)	2.64
Beta (5Y)	1.13
Change from 52-week high	-55.03%
Change from 52-week low	33.46%
Change from all-time high	-91.45%
Change from all-time low	44.59%
Change from open	10.64%
Day's gap	-0.3%
Dollar volume	$12.8M
High price	$7.29
Low price	$6.58
Monthly RSI	42.19
Open price	$6.58
Position in 52-week range	98.59%
Premarket change	0%
Premarket close	$6.60
Premarket price	$6.60
Premarket volume	370
Previous close	$6.60
Price vs 150-day SMA	-18.62%
Price vs 20-day SMA	-0.16%
Price vs 200-day SMA	-21.28%
Price vs 50-day SMA	-10.71%
Relative volume	1.3
RSI	47.4
Sharpe ratio	-0.24
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	-0.1
Sortino ratio	-0.26
Sortino ratio (3Y)	0.17
Sortino ratio (5Y)	-0.07
Volume	1.8M
Weekly RSI	43.66
YTD price change	-49.44%
YTD total return	-49.44%

Metric

Value

10Y price change

-55.34%

10Y return CAGR

-7.75%

10Y total return

-55.34%

150-day SMA

$8.95

1D price change

10.3%

1M price change

-1.62%

1M total return

-1.62%

1W price change

1.53%

1W total return

1.53%

1Y price change

-46.55%

1Y return CAGR

-46.57%

1Y total return

-46.55%

20-day SMA

$7.29

200-day SMA

$9.25

3M price change

-25.03%

3M total return

-25.03%

3Y price change

-49.37%

3Y return CAGR

-20.3%

3Y total return

-49.37%

50-day SMA

$8.15

50-day SMA vs 200-day SMA

50under200

52-week high

$16.19

52-week high date

2026-01-22

52-week low

$5.46

52-week low date

2026-05-18

5Y price change

-79.33%

5Y return CAGR

-27.05%

5Y total return

-79.33%

6M price change

-15.55%

6M total return

-15.55%

All-time high

$85.10

All-time high date

2018-07-10

All-time low

$5.04

All-time low date

2025-04-09

Average true range (ATR)

$0.49

Average volume

1.4M

Beta (1Y)

3.03

Beta (2Y)

2.64

Beta (5Y)

1.13

Change from 52-week high

-55.03%

Change from 52-week low

33.46%

Change from all-time high

-91.45%

Change from all-time low

44.59%

Change from open

10.64%

Day's gap

-0.3%

Dollar volume

$12.8M

High price

$7.29

Low price

$6.58

Monthly RSI

42.19

Open price

$6.58

Position in 52-week range

98.59%

Premarket change

Premarket close

$6.60

Premarket price

$6.60

Premarket volume

370

Previous close

$6.60

Price vs 150-day SMA

-18.62%

Price vs 20-day SMA

-0.16%

Price vs 200-day SMA

-21.28%

Price vs 50-day SMA

-10.71%

Relative volume

1.3

RSI

47.4

Sharpe ratio

-0.24

Sharpe ratio (3Y)

0.07

Sharpe ratio (5Y)

-0.1

Sortino ratio

-0.26

Sortino ratio (3Y)

0.17

Sortino ratio (5Y)

-0.07

Volume

1.8M

Weekly RSI

43.66

YTD price change

-49.44%

YTD total return

-49.44%

Metric	Value
Float	57.2M
Float percentage	86.7%
Shares change (QoQ)	1.12%
Shares change (YoY)	2.03%
Shares held by insiders	6.69%
Shares held by institutions	59.38%
Shares outstanding	66M
Short % of float	16.79%
Short % of shares	14.56%
Short ratio	7.1 days

Metric

Value

Float

57.2M

Float percentage

86.7%

Shares change (QoQ)

1.12%

Shares change (YoY)

2.03%

Shares held by insiders

6.69%

Shares held by institutions

59.38%

Shares outstanding

66M

Short % of float

16.79%

Short % of shares

14.56%

Short ratio

7.1 days

REGENXBIO Inc. (RGNX)

Price

Financial snapshot

Fair-value bridge

Latest news · RGNX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RGNX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RGNX

Frequently asked questions